drugset / Trial / NCT03659461

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

NCT03659461

Completed 174 enrolled National University of Malaysia
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is conducted to examine GLP-1, insulin resistance and insulin sensitivity portfolio in Malay, Chinese and Indian populations in Malaysia and to study the effect of DPPIV inhibitor in T2DM patients with different GLP-levels.

Timeline

Start
2017-10-01
Primary completion
2019-12-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg Oral